Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996877 · ClinicalTrials.gov registry record
Outcomes of Surgically Ineligible Patients With Multivessel CAD
A clinical trial, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- 750
- Enrollment target
NCT02996877 is a clinical trial that has completed, run by Saint Luke's Health System. The registered enrollment target is 750 participants.
The verdict
NCT02996877 has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease ("surgical anatomy" according to ACC/AHA Appropriateness Criteria for PCI12) and are deemed ineligible for coronary artery bypass surgery. It is anticipated that 20 sites will be selected to participate in the registry from a national network of leading centers across the United States with recognized expertise in both complex PCI and coronary artery bypass surgery. We will invite leading cardiac centers, as defined by US News and World reports rankings for heart care. Additional sites may be added to meet the target enrollment goal.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2016-12-15 |
| Est. Completion | 2020-06-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02996877
The ClinicalTrials.gov registry entry for NCT02996877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02996877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02996877 about?
NCT02996877 is a clinical study titled "Outcomes of Surgically Ineligible Patients With Multivessel CAD". The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease ("surgical anatomy" according to ACC/AHA Appropriateness Criteria for PCI12) and are deemed ineligible for coronary artery byp...
What is the current status of trial NCT02996877?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2016-12-15. Estimated completion is 2020-06-22.
Who is sponsoring clinical trial NCT02996877?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.